2 Result: AVROBIO
Ault Alliance Soars On Financial Status; AVROBIO Climbs On Strategic Leap
July 12th, 2023
Shares of Ault Alliance, Inc. (NYSE American: AULT) surged over 100% in pre-market trading after the company provided a business update highlighting its financial status. With approximately 2.1 million shares outstanding and a book value of around. Read more
AVROBIO Sells Cystinosis Therapy Program to Novartis, Stock Surges; Compass Minerals Inks Lithium Supply Deal with Ford; Global-e Online Beats Estimates, Stock Declines
May 22nd, 2023
AVROBIO, Inc. (Nasdaq: AVRO) has made a significant announcement, revealing that it has entered into an agreement to sell its investigational hematopoietic stem cell (HSC) gene therapy program for the treatment of cystinosis to Novartis (NYSE: NVS). . Read more
Want To Find Some News?
News By Industries
Recent Post
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026
Member Login